Skip to content

Interest Expense at other companies

Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
-$39.9M+25.7%
Alkermes logo
AlkermesALKS
$20.89M
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$3.4M+17.6%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
-$53.36M+6.3%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$8.06M+1.9%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$19.78M-15.8%

Segments

By segment

See full
Rare Neurological Diseases$3.23M-15.7%

Other financials

Income statement

See full
Revenue$215.4M+16.6%
Gross profit$170.9M+11.9%
Operating income$37.3M-33.7%
Net income$32.5M-28.7%
EPS (diluted)$0.55-29.5%

Balance sheet

See full
Cash & equivalents$589.4M+20.5%
Total debt$164.6M-7.2%
Total equity$910.3M+26.3%
Total assets$1.3B+20.5%

Cash flow

See full
Operating cash flow$27.8M-18.3%
CapEx$107.0K-79.1%
Free cash flow$126.0M+67.9%

Valuation

See full
Market cap$1.98B-14.9%
Enterprise value$1.55B-24.9%
P/E13.6×-1.6×
P/S2.2×-0.9×

Profitability

See full
Gross margin76.5%-1.8pp
Operating margin21.1%-5.1pp
Net margin16.2%-4.3pp
FCF margin40.1%+9.5pp

Returns & leverage

See full
Return on equity17.9%-6.9pp
Debt / equity0.2×-0.1×
Current ratio3.6×-0.1×

Where this comes from

Reported directly by Harmony Biosciences Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.

The official record: Harmony Biosciences Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harmony Biosciences Holdings, Inc.'s interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harmony Biosciences Holdings, Inc.'s interest expense?
Harmony Biosciences Holdings, Inc. (HRMY) reported interest expense of $3.23M in Q1 2026.
How has Harmony Biosciences Holdings, Inc.'s interest expense changed year-over-year?
Harmony Biosciences Holdings, Inc.'s interest expense decreased by 15.7% year-over-year, from $3.84M to $3.23M.
What is the long-term trend for Harmony Biosciences Holdings, Inc.'s interest expense?
Over 4 years (2021 to 2025), Harmony Biosciences Holdings, Inc.'s interest expense has grown at a -11.8% compound annual growth rate (CAGR), from $24.19M to $14.65M.
What does interest expense mean?
Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.